Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
October 1, 1982
Human ocular mucus. Scanning electron microscopic study
J V Greiner, D R Korb, H I Covington, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 3, 2025
Oxidative pentose phosphate pathway is required for T cell activation and antitumor immunity
Zihong Chen, Kellen L Olszewski, Rolf-Peter Ryseck, et al.
Nature Metabolism
|
December 12, 2024
Author Correction: Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenase
Shane M O'Carroll, Christian G Peace, Juliana E Toller-Kawahisa, et al.
Nature Metabolism
|
October 15, 2024
Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenase
Shane M O'Carroll, Christian G Peace, Juliana E Toller-Kawahisa, et al.
Cell Metabolism
|
March 2, 2022
Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages
Marah C Runtsch, Stefano Angiari, Alexander Hooftman, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Mapping the mammalian dark metabolome by <i>in vivo</i> isotope tracing
Michael R MacArthur, Justine Raeber, Wenyun Lu, et al.
Nature
|
March 8, 2023
Macrophage fumarate hydratase restrains mtRNA-mediated interferon production
Alexander Hooftman, Christian G Peace, Dylan G Ryan, et al.
Nature Communications
|
June 14, 2023
Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon
Tristram A J Ryan, Alexander Hooftman, Aisling M Rehill, et al.
Nature Communications
|
July 20, 2023
Publisher Correction: Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon
Tristram A J Ryan, Alexander Hooftman, Aisling M Rehill, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
October 1, 1982
Human ocular mucus. Scanning electron microscopic study
J V Greiner, D R Korb, H I Covington, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 3, 2025
Oxidative pentose phosphate pathway is required for T cell activation and antitumor immunity
Zihong Chen, Kellen L Olszewski, Rolf-Peter Ryseck, et al.
Nature Metabolism
|
December 12, 2024
Author Correction: Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenase
Shane M O'Carroll, Christian G Peace, Juliana E Toller-Kawahisa, et al.
Nature Metabolism
|
October 15, 2024
Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenase
Shane M O'Carroll, Christian G Peace, Juliana E Toller-Kawahisa, et al.
Cell Metabolism
|
March 2, 2022
Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages
Marah C Runtsch, Stefano Angiari, Alexander Hooftman, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Mapping the mammalian dark metabolome by <i>in vivo</i> isotope tracing
Michael R MacArthur, Justine Raeber, Wenyun Lu, et al.
Nature
|
March 8, 2023
Macrophage fumarate hydratase restrains mtRNA-mediated interferon production
Alexander Hooftman, Christian G Peace, Dylan G Ryan, et al.
Nature Communications
|
June 14, 2023
Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon
Tristram A J Ryan, Alexander Hooftman, Aisling M Rehill, et al.
Nature Communications
|
July 20, 2023
Publisher Correction: Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon
Tristram A J Ryan, Alexander Hooftman, Aisling M Rehill, et al.
Page
of 4